Ivonescimab's Updated Label Shows Positive Dual Results in PFS and OS from HARMONi-A Study
PR Newswire —
HONG KONG, Jan. 6, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced that the National Medical Products Administration has approved a significant label update in China for its internally developed, first-in-class PD-1/VEGF bispecific antibody, ivonescimab. The updated label...